GERMANTOWN, Maryland, June 11, 2012 /PRNewswire/ --
World leader of shockwave therapy solutions benefits from new product development, territory expansion and market growth
Medispec, a world leader in shockwave therapy, has announced a new phase of rapid expansion for their clinically-effective medical solutions. Medispec's non-invasive medical treatments have paved new paths within the global medical community, becoming the preferred treatment method for a wide range of health issues. Traditionally used for kidney stones, the non-invasive treatment has spread to the areas of cardiology, orthopedics and cellulite control - and all with excellent results. Medispec recently made headlines with its revolutionary treatments for ischemic heart disorder (ISD) and erectile dysfunction (ED).
As a response to the high demand by physicians and clinics worldwide, Medispec has broadened its global sales reach and increased its level of product support to markets around the globe. The company has extended the scope and number of clinical trials conducted in cooperation with industry leaders and specialists and has enlarged its network of partnerships with medical experts.
Headquartered in the US, Medispec has expanded its global network of distributors and satellite offices, which currently includes a network of more than 80 local distributors in the majority of countries worldwide. In addition, the company has over 3000 installations at governments, universities, hospitals, and private institutions.
Established in 1992, Medispec's line of innovative, high-performance shockwave technology systems is customized for a wide range of medical treatments. Medispec's innovative and cost-effective treatments eliminate the need for invasive procedures, anesthesia and undesirable side effects. The majority of Medispec products comply with FDA and CE regulations.
SOURCE Medispec Ltd.